Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 27,114 | 28,430 | 25,875 | 24,199 | 23,754 |
| Operating Income | -27,114 | -28,430 | -25,875 | -24,199 | -23,754 |
| Other Income | -45 | 12 | 47 | 20 | 65 |
| Pre-tax Income | -27,159 | -28,418 | -25,828 | -24,179 | -23,689 |
| Net Income Continuous | -27,159 | -28,418 | -25,828 | -24,179 | -23,689 |
| Net Income | $-27,159 | $-28,418 | $-25,828 | $-24,179 | $-23,689 |
| EPS Basic Total Ops | -1.04 | -1.09 | -0.99 | -1.00 | -1.09 |
| EPS Basic Continuous Ops | -1.05 | -1.09 | -0.99 | -1.00 | -1.08 |
| EPS Diluted Total Ops | -1.04 | -1.09 | -0.99 | -1.00 | -1.09 |
| EPS Diluted Continuous Ops | -1.05 | -1.09 | -0.99 | -1.00 | -1.08 |
| EBITDA(a) | $-25,889 | $-27,208 | $-24,715 | $-23,109 | $-22,643 |